R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_temporal Arg1:T3 Arg2:T4	
R3	Subsumes Arg1:T4 Arg2:T5	
R4	Has_value Arg1:T6 Arg2:T7	
R5	AND Arg1:T8 Arg2:T6	
R6	Has_multiplier Arg1:T9 Arg2:T10	
R7	Has_value Arg1:T13 Arg2:T14	
R8	Has_value Arg1:T11 Arg2:T12	
R9	Has_multiplier Arg1:T16 Arg2:T17	
R10	Subsumes Arg1:T9 Arg2:T11	
R11	Has_value Arg1:T21 Arg2:T22	
R14	Subsumes Arg1:T27 Arg2:T28	
R15	Has_multiplier Arg1:T26 Arg2:T27	
R12	AND Arg1:T23 Arg2:T24	
*	OR T24 T25 T26
*	OR T30 T31
*	OR T32 T33
R13	AND Arg1:T30 Arg2:T32	
T1	Person 0 3	Age
T2	Value 4 30	between 18 and 78 year-old
T3	Procedure 42 63	liver transplantation
T4	Temporal 33 41	Previous
T5	Temporal 64 81	more than 6 month
T6	Measurement 85 93	Genotype
T7	Value 94 101	1 and 4
T8	Condition 102 111	infection
T9	Condition 114 125	Hepatitis C
T10	Multiplier 126 136	recurrence
T11	Measurement 173 192	liver function test
T12	Value 164 172	abnormal
T13	Measurement 203 210	HCV-RNA
T14	Value 194 202	positive
T15	Procedure 212 224	histological
T16	Condition 234 245	hepatitis C
T17	Multiplier 246 256	recurrence
T18	Condition 212 256	histological signs of hepatitis C recurrence
T21	Measurement 259 269	Viral load
T22	Value 270 281	≥10000UI/mL
T23	Procedure 284 301	Immunosuppression
T24	Drug 307 317	tacrolimus
T25	Drug 325 338	mycophenolate
T26	Drug 340 350	Prednisone
T27	Multiplier 369 377	low dose
T28	Value 379 387	≤10 mg/d
T30	Condition 391 406	Treatment naïve
T31	Condition 410 431	treatment experienced
T32	Procedure 433 440	Peg-RBV
T33	Procedure 444 458	triple therapy
